The in vitro detection of botulinum neurotoxin-cleaved endogenous VAMP is epitope-dependent.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Toxicology in Vitro

• Publication date

  2018-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.tiv.2018.01.016PMID 29373835
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Cell Line for Detection of Botulinum Neurotoxin Type B

  2017cited by this paper
• Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins

  2016cited by this paper
• Progress in cell based assays for botulinum neurotoxin detection.

  2013cited by this paper
• Current Methods for Detecting the Presence of Botulinum Neurotoxins in Food and Other Biological Samples

  2012cited by this paper
• Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection.

  2012cited by this paper
• Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B.

  2011cited by this paper
• Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination.

  2010cited by this paper
• A neuronal cell‐based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies

  2007cited by this paper
• An in vitro assay for detection of tetanus neurotoxin activity: using antibodies for recognizing the proteolytically generated cleavage product.

  2007cited by this paper
• Progress in Applying the Three Rs to the Potency Testing of Botulinum Toxin Type A

  2006cited by this paper
• Preparation of specifically activatable endopeptidase derivatives of Clostridium botulinum toxins type A, B, and C and their applications.

  2005cited by this paper
• Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells.

  2004cited by this paper
• Evaluation of the Therapeutic Usefulness of Botulinum Neurotoxin B, C1, E, and F Compared with the Long Lasting Type A

  2003cited by this paper
• Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells.

  2001cited by this paper
• Neurotoxins affecting neuroexocytosis.

  2000cited by this paper
• Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond.

  1994cited by this paper
• Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

  1992cited by this paper

• An emerging role of SNAREs in ischemic stroke: From pre-to post-diseases.

  2025cites this paper
• Detection of VAMP Proteolysis by Tetanus and Botulinum Neurotoxin Type B In Vivo with a Cleavage-Specific Antibody

  2022cites this paper
• Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology

  2019cites this paper
• Duplication of clostridial binding domains for enhanced macromolecular delivery into neurons

  2019cites this paper
• Functional detection of botulinum neurotoxin serotypes A-F by monoclonal neoepitope-specific antibodies

  2019cites this paper